Detail akcie Iconovo Rg online

Business Summary: Iconovo AB is a Sweden-based company, which offers inhalation solutions for pharmaceutical companies. Solutions are based on the Company’s device platforms and include formulation, analytical testing and documentation. Iconovo Ab develops products, which are a part of device family and include: ICOres, reservoir devices, ICOone, disposable unit-dose devices, ICOcap, capsule-based devices and ICOpre, pre-metered devices. Moreover, the Company offers programs, which include development of generic inhalation products, where the products are registered based on therapeutic equivalence; development of inhalation products based on a generic application programming interface (API) and new chemical entity (NCE); as well as phase I-II clinical trials using ICOone.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Iconovo AB revenues decreased 62% to SEK1.1M. Net loss increased 5% to SEK43.4M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Other Operating Income decrease of 47% to SEK706K (income). Basic Earnings per Share excluding Extraordinary Items increased from -SEK2.33 to -SEK1.14.